AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 9125680
Drug: Acetylcholine (0.15,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acetylcholine (0.15, 0.45, 1.5, 4.5, and 15 microg/100 ml forearm tissue/min)
Trial: 7648143
Drug: Daflon 500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daflon 500 mg for 1 week after operation (group 1)
Trial: 2744313
Drug: Gallopamil 25
RxNorm normalized name: gallopamil 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gallopamil 25 mg tid
Trial: 8355859
Drug: Gallopamil 50
RxNorm normalized name: gallopamil 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gallopamil 50 mg tid
Trial: 25278342
Drug: No-treatment control
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No-treatment control group (trial-matched cognitive task)
Trial: 23298651
Drug: Varenicline (1mg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Varenicline (1mg twice per day)
Trial: 12971556
Drug: DNP (dihydroartemisinin-napthoquine-trimethoprim),
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DNP (dihydroartemisinin-napthoquine-trimethoprim), one tablet twice a day for one day
Trial: 6142218
Drug: No specific
RxNorm normalized name: Oregano specific IgE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No specific treatment (Control)
Trial: 1297643
Drug: 600 mg
RxNorm normalized name: mesna 600 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 600 mg granular ibuprofen
Trial: 6395810
Drug: Twice daily
RxNorm normalized name: CAPSULE, TWICE DAILY
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Twice daily sustained release theophylline
Trial: 31783739
Drug: DHA-rich fish
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DHA-rich fish oil supplement
Trial: 18263802
Drug: Dichloroacetate (DCA)
RxNorm normalized name: dichloroacetate
DrugBank: Sodium dichloroacetate (DB16929)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dichloroacetate (DCA) infusion (50 mg/kg body mass)
Trial: 17466725
Drug: Medications and
RxNorm normalized name: allogeneic cultured keratinocytes and dermal fibroblasts in murine collagen Medicated Patch [Stratagraft]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medications and cryobrace alone (Control group)
Trial: 2388876
Drug: Home therapeutic
RxNorm normalized name: Moisturel Therapeutic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Home therapeutic drug-monitoring (TDM) method for theophylline blood levels
Trial: 31566937
Drug: Cabazitaxel (25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cabazitaxel (25 mg/m² IV every 3 weeks, plus prednisone daily and granulocyte colony-stimulating factor)
Trial: 31566937
Drug: Androgen-signaling-targeted inhibitor
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Androgen-signaling-targeted inhibitor (1000 mg of abiraterone plus prednisone daily or 160 mg of enzalutamide daily)
Trial: 31566937
Drug: Androgen-signaling-targeted inhibitor
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Androgen-signaling-targeted inhibitor
Trial: 27847247
Drug: Water administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Water administered throughout CRT (group C)
Trial: 19216850
Drug: Traditional Chinese
RxNorm normalized name: BORNEOL 1 g in 6.5 g / MINT 1 g in 6.5 g / ANGELICA DAHURICA ROOT 0.5 g in 6.5 g TOPICAL POWDER [Traditional Chinese Medicine Health Card and TCM Epidemic Prevention Card]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Traditional Chinese medicine (TCM) therapy for clearing heat and resolving phlegm combined with routine Western medicine.
Trial: 19216850
Drug: Routine Western
RxNorm normalized name: western larch pollen extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Routine Western medicine only (control group).
Trial: 3105748
Drug: Thyroxine (150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thyroxine (150 micrograms daily)
Trial: 27607036
Drug: 2% Potentilla
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2% Potentilla officinalis (PO) cream
Trial: 27607036
Drug: 1% hydrocortisone
RxNorm normalized name: HYDROCORTISONE 0.01 g in 1 g TOPICAL OINTMENT [AFASSCO 1% Hydrocortisone]
DrugBank: Hydrocortisone (DB00741)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: 1% hydrocortisone acetate cream
Trial: 18721243
Drug: Dexamethasone 21‐P
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexamethasone 21‐P (Dex 21‐P) encapsulated into erythrocytes (DEE), 9.9 +/- 4.1 mg per infusion, two infusions 14 days apart (group A)
Trial: 18721243
Drug: Oral prednisolone
RxNorm normalized name: prednisolone Oral Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral prednisolone (0.5 mg/kg for 14 days followed by a 6 mg/weekly tapering, group B)
Trial: 18721243
Drug: Sham infusions
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sham infusions (group C)
Trial: 10343133
Drug: La1 supernatant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: La1 supernatant with omeprazole 20 mg four times a day
Trial: 7438683
Drug: Ethanol 0.7
RxNorm normalized name: ethanol 0.7 ML/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ethanol 0.7 gm/kg orally over 15 min followed by diazepam 10 mg intravenously over 20 min and ethanol 0.15 gm/kg/hr for 8 hr
Trial: 7438683
Drug: Diazepam 10
RxNorm normalized name: diazepam 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diazepam 10 mg intravenously over 20 min
Trial: 10458050
Drug: Caffeine (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Caffeine (5 mg/kg)
Trial: 11331168
Drug: 0.125% bupivacaine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.125% bupivacaine with fentanyl (2 micro g.ml(‐1))
Trial: 11331168
Drug: 0.125% bupivacaine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.125% bupivacaine with sufentanil (0.25 micro g.ml(‐1))
Trial: 20693884
Drug: Fentanyl-acetaminophen group
RxNorm normalized name: Fentanyl
DrugBank: Fentanyl (DB00813)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Fentanyl-acetaminophen group
Trial: 18997143
Drug: Odds ratio
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Odds ratio for African Americans not filling prescriptions
Trial: 1612904
Drug: 3 x
RxNorm normalized name: Xenon (133 xe)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3 x 10(6) IU rIFN‐beta per injection
Trial: 6323783
Drug: Two-drug combination
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Two-drug combination (ACNU . VCR, ADM . VCR)
Trial: 6323783
Drug: Three-drug combination
RxNorm normalized name: three-lobe sage extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Three-drug combination (ACNU . CPA . VCR, ACNU . ADM . VCR)
Trial: 27233251
Drug: Aminophylline (75
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aminophylline (75 mg administered intravenously 90 seconds after 99mTc-tetrofosmin injection)
Trial: 24129130
Drug: Initial infliximab
RxNorm normalized name: Infliximab
DrugBank: Infliximab (DB00065)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Initial infliximab treatment
Trial: 24129130
Drug: Delayed infliximab
RxNorm normalized name: Infliximab
DrugBank: Infliximab (DB00065)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Delayed infliximab treatment (in arms 1-3)
Trial: 24129130
Drug: Post-discontinuation of
RxNorm normalized name: post oak pollen extract
DrugBank: Quercus stellata pollen (DB10888)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Post-discontinuation of infliximab
Trial: 17283346
Drug: Ambulatory CPAP
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ambulatory CPAP titration
Trial: 11445632
Drug: Testosterone enanthate
RxNorm normalized name: Testosterone Enanthate
DrugBank: Testosterone enanthate (DB13944)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Testosterone enanthate (100 mg weekly intramuscular injections)
Trial: 3064254
Drug: Veralipride (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Veralipride (1 tablet per day for 20 days)
Trial: 24090379
Drug: Combined treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined treatment with simvastatin (40 mg/day) and ezetimibe (20 mg/day)
Trial: 24090379
Drug: Monotherapy with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Monotherapy with simvastatin (80 mg/day)
Trial: 21355151
Drug: Du-moxibustion combined
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Du-moxibustion combined with western medicine (herb-partitioned spread moxibustion on the Governor Vessel between Dazhui (GV 14) and Yaoshu (GV 2))
Trial: 14563190
Drug: Diuretics plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diuretics plus albumin (n = 63)
Trial: 14563190
Drug: Albumin treatment
RxNorm normalized name: Albumin Aggregated
DrugBank: Albumin Aggregated (DB14230)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Albumin treatment (25 g/week)
Trial: 14563190
Drug: Albumin treatment
RxNorm normalized name: Albumin Aggregated
DrugBank: Albumin Aggregated (DB14230)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Albumin treatment
Trial: 10852611
Drug: 2.4 mg/day
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2.4 mg/day of folic acid (FA), 50.0 mg/day of vitamin B6, 0.4 mg/day of vitamin B12
Trial: 10852611
Drug: 15 mg/day
RxNorm normalized name: Climara Pro 0.045/0.015 MG/Day Weekly Transdermal System
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 15 mg/day of folic acid (FA) or 17 mg/day of L-5-methyltetrahydrofolate, 50.0 mg/day of vitamin B6, 1.0 mg/day of vitamin B12
Trial: 9583629
Drug: Nicotine Replacement
RxNorm normalized name: Nicotine
DrugBank: Nicotine (DB00184)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nicotine Replacement Therapy (NRT) - subjects could select one product of their choice or were randomly assigned a product during the study weeks.
Trial: 30182639
Drug: NSPT plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: NSPT plus anti-oxidant gel formula (propolis)
Trial: 30182639
Drug: NSPT plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: NSPT plus chlorhexidine gel formula
Trial: 27271087
Drug: Asenapine 5
RxNorm normalized name: asenapine 5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Asenapine 5 mg bid
Trial: 27271087
Drug: Asenapine 10
RxNorm normalized name: asenapine 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Asenapine 10 mg bid
Trial: 22264742
Drug: Alcohol hand
RxNorm normalized name: Medpura Isopropryl Alcohol Hand Sanitizer
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alcohol hand gel application every 60 minutes (q 60)
Trial: 22264742
Drug: Alcohol hand
RxNorm normalized name: Medpura Isopropryl Alcohol Hand Sanitizer
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alcohol hand gel application every 120 minutes (q 120)
Trial: 22264742
Drug: Alcohol hand
RxNorm normalized name: Medpura Isopropryl Alcohol Hand Sanitizer
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alcohol hand gel application only before lunch (q lunch)
Trial: 12461065
Drug: Clopidogrel (300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clopidogrel (300 mg single dose)
Trial: 12461065
Drug: Clopidogrel (longer
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clopidogrel (longer treatment, four days)
Trial: 37142
Drug: Prifinium bromide
RxNorm normalized name: prifinium bromide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prifinium bromide (90 mg daily before meals)
Trial: 25046055
Drug: DPP-4 inhibitor
RxNorm normalized name: Fibrinolysis inhibitor
DrugBank: Aprotinin (DB06692)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: DPP-4 inhibitor
Trial: 21389739
Drug: Sub-Tenon (ST)
RxNorm normalized name: tenonitrozole
DrugBank: Tenonitrozole (DB13659)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sub-Tenon (ST) posterior triamcinolone injection (ST group)
Trial: 15151523
Drug: Fosfluconazole (1000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fosfluconazole (1000 mg intravenous bolus injection)
Trial: 8871872
Drug: Interferon (IFN)
RxNorm normalized name: Interferon Gamma
DrugBank: Interferon Gamma (DB15753)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Interferon (IFN) therapy
Trial: 17900941
Drug: Bur treatment
RxNorm normalized name: bur oak pollen extract
DrugBank: Quercus macrocarpa pollen (DB10738)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bur treatment
Trial: 30689222
Drug: T3 infusion
RxNorm normalized name: T3
DrugBank: Liothyronine (DB00279)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: T3 infusion for eight hours
Trial: 30689222
Drug: T4 infusion
RxNorm normalized name: T4
DrugBank: Levothyroxine (DB00451)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: T4 infusion for eight hours
Trial: 28488462
Drug: Sham treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sham treatment (Group S)
Trial: 21392851
Drug: Mitomycin C
RxNorm normalized name: Mitomycin C
DrugBank: Mitomycin (DB00305)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Mitomycin C (0.2 mg/dL)
Trial: 17101640
Drug: Pioglitazone (15-45
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pioglitazone (15-45 mg/d)
Trial: 17101640
Drug: Glimepiride (1-4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glimepiride (1-4 mg/d)
Trial: 9416856
Drug: Intravenous pulse
RxNorm normalized name: dulse extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous pulse cyclophosphamide (CYC) with prednisone (group A)
Trial: 29486367
Drug: Single dose
RxNorm normalized name: Citrucel Single Dose Packets (Orange)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single dose of 150,000 IU vitamin D3
Trial: 29486367
Drug: Daily dose
RxNorm normalized name: LENVIMA 8mg Daily Dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily dose of 5000 IU vitamin D3
Trial: 28069076
Drug: 55-g rye
RxNorm normalized name: Rye
DrugBank: Rye (DB10564)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 55-g rye porridge
Trial: 18979160
Drug: Single dose
RxNorm normalized name: Citrucel Single Dose Packets (Orange)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single dose of 300,000 IU cholecalciferol
Trial: 15959426
Drug: Micronized fenofibrate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Micronized fenofibrate 200 mg
Trial: 15959426
Drug: Micronized fenofibrate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Micronized fenofibrate 200 mg and Vitamin E 400 IU
Trial: 12773957
Drug: Transdermal 17beta
RxNorm normalized name: 17beta oestradiol
DrugBank: Estradiol (DB00783)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Transdermal 17beta oestradiol
Trial: 12773957
Drug: Oral ethinyl
RxNorm normalized name: ethinyl estradiol Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral ethinyl oestradiol, conjugated equine oestrogen, oestradiol valerate
Trial: 12773957
Drug: Oral oestrogen
RxNorm normalized name: estrogens
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral oestrogen
Trial: 12773957
Drug: Transdermal oestrogen
RxNorm normalized name: estrogens
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transdermal oestrogen
Trial: 8568424
Drug: Low-level laser
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-level laser in the upper cervical region and deep friction massage in the lower cervical/upper thoracic region, twice/wk for 3 wk
Trial: 1814714
Drug: Glass ionomer
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glass ionomer cement (Fuji II/G‐C Dental)
Trial: 1814714
Drug: Sandwich restoration
RxNorm normalized name: DRESSING,RESTORE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sandwich restoration (Lining Cement/G‐C Dental)
Trial: 31669890
Drug: Low-dose interleukin-2
RxNorm normalized name: Interleukin-2 aldesleukin
DrugBank: Aldesleukin (DB00041)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Low-dose interleukin-2 (ld-IL2) combined with conventional therapy in 35 patients
Trial: 20558004
Drug: Crystalloid (Hartmann's
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Crystalloid (Hartmann's solution)
Trial: 17401606
Drug: Long-acting medications
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Long-acting medications for ADHD
Trial: 7514366
Drug: 16 mg
RxNorm normalized name: escin 16 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 16 mg of risperidone
Trial: 1379883
Drug: 20 mg
RxNorm normalized name: urea 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg of haloperidol
Trial: 20180789
Drug: Dexlansoprazole MR
RxNorm normalized name: Dexlansoprazole
DrugBank: Dexlansoprazole (DB05351)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Dexlansoprazole MR 60 mg before breakfast
Trial: 20180789
Drug: Dexlansoprazole MR
RxNorm normalized name: Dexlansoprazole
DrugBank: Dexlansoprazole (DB05351)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Dexlansoprazole MR 60 mg before lunch
Trial: 20180789
Drug: Dexlansoprazole MR
RxNorm normalized name: Dexlansoprazole
DrugBank: Dexlansoprazole (DB05351)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Dexlansoprazole MR 60 mg before dinner
Trial: 20180789
Drug: Dexlansoprazole MR
RxNorm normalized name: Dexlansoprazole
DrugBank: Dexlansoprazole (DB05351)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Dexlansoprazole MR 60 mg before evening snack
Trial: 8942890
Drug: 0.005% latanoprost
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.005% latanoprost applied topically once daily for 12 months
Trial: 28660441
Drug: Paclitaxel-resveratrol drug
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Paclitaxel-resveratrol drug matrix-coated balloon catheter (DCB)
Trial: 15040645
Drug: Symptom profile
RxNorm normalized name: Pamprin Multi-Symptom
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Symptom profile and side effects from antihypertensive drugs
Trial: 15040645
Drug: Drug therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Drug therapy compliance
Trial: 8042129
Drug: Single-dose oral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single-dose oral therapy for gonorrhea (cefixime, ciprofloxacin, ofloxacin)
Trial: 8042129
Drug: Single-dose oral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single-dose oral therapy for chlamydia (azithromycin)
Trial: 8042129
Drug: Single-dose oral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single-dose oral therapy for chancroid (azithromycin)
Trial: 8042129
Drug: Outpatient therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Outpatient therapy for pelvic inflammatory disease (ofloxacin and either clindamycin or metronidazole)
Trial: 8042129
Drug: Patient-applied therapy
RxNorm normalized name: lansoprazole
DrugBank: Lansoprazole (DB00448)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Patient-applied therapy for genital warts (podofilox)
Trial: 8042129
Drug: Syphilis therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Syphilis therapy
Trial: 3542851
Drug: Zidometacin (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zidometacin (400 mg p.o.)
Trial: 3542851
Drug: Zidometacin (600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zidometacin (600 mg rectal)
Trial: 19299776
Drug: Pregabalin 150
RxNorm normalized name: pregabalin 150 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pregabalin 150 mg
Trial: 11179983
Drug: Low M
RxNorm normalized name: Peak Flow Meter
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low M (omeprazole 20 mg twice daily, amoxycillin 1,000 mg twice daily, metronidazole 400 mg twice daily)
Trial: 6141114
Drug: Loprazolam (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Loprazolam (1 mg)
Trial: 30944068
Drug: Drug Coated
RxNorm normalized name: Drug coated stent
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Drug Coated Balloon (DCB; coated with paclitaxel)
Trial: 25369243
Drug: Atomoxetine 1.2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atomoxetine 1.2 mg/kg/day
Trial: 19580719
Drug: Low-flow AS
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-flow AS (defined as stroke volume index <22 ml/m²)
Trial: 9480993
Drug: Inhaled nitric
RxNorm normalized name: nitric oxide Inhalant Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled nitric oxide (NO) at doses of 5, 20, or 80 ppm
Trial: 30056389
Drug: Screening test
RxNorm normalized name: mumps skin test antigen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Screening test indicated aspirin
Trial: 15313296
Drug: Lidocaine 2%
RxNorm normalized name: LIDOCAINE 2% GEL,TOP
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lidocaine 2% gel
Trial: 7555484
Drug: Policosanol (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Policosanol (5 mg, twice a day for 12 weeks)
Trial: 7293522
Drug: Naprosyn 500
RxNorm normalized name: Naprosyn 500mg Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Naprosyn 500 mg suppositories
Trial: 7293522
Drug: Naprosyn tablets
DrugBank: Naproxen (DB00788)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Naprosyn tablets
Trial: 24976429
Drug: Placebo, twice
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo, twice daily for 12 weeks
Trial: 21352079
Drug: Rosuvastatin (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rosuvastatin (10 mg/day) plus Telmisartan (80 mg/day)
Trial: 15042114
Drug: Eprosartan monotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Eprosartan monotherapy
Trial: 11504275
Drug: AP1903 0.01
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AP1903 0.01 mg/kg
Trial: 11504275
Drug: AP1903 0.05
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AP1903 0.05 mg/kg
Trial: 11504275
Drug: AP1903 0.1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AP1903 0.1 mg/kg
Trial: 11504275
Drug: AP1903 0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AP1903 0.5 mg/kg
Trial: 20042925
Drug: Oral rehydration
RxNorm normalized name: Oral rehydration salt formulations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral rehydration
Trial: 9360205
Drug: Oral rehydration
RxNorm normalized name: Oral rehydration salt formulations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral rehydration followed by Lactobacillus casei strain GG
Trial: 8285751
Drug: Lactobacillus GG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lactobacillus GG 10(8) colony forming units twice a day for two weeks